FindTrial
Sign In

Sleep disordered breathing in heart failure patients and the over-night effect of different Adaptive Sero-Ventilation in heart-failure patients with central sleep apnea

Sleep disordered breathing in heart failure patients and the over-night effect of different Adaptive Sero-Ventilation in heart-failure patients with central sleep apnea

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008008
Enrollment
Unknown
Registered
2016-02-26
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central sleep apnea

Interventions

one:ASV

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. adults aged 18~80 years old; 2. LVEF<=45%, NYHA II~III; have standard treatment, ACEI,beta blocker, diuretics.

Exclusion criteria

Exclusion criteria: (1) angina pectoris or myocardial infarction within 3 months; with acute myocarditis, pericarditis during last 6 months; (2) the kidney failure, Dialysis nervous systerm disease, respiratory disease (COPD FEV1 < 50% pre; resting SpO2 < 90%); (3) history of pneumothorax or pneumo-mediastinum; (4) the restless legs syndrome; (5) history of stroke; (6) have hypnotics; (7) history of Surgery of otolaryngology; (8) need oxygen treatment, during PAP treatment; (9) pregnancy or in lactation period.

Design outcomes

Primary

MeasureTime frame
PSG;NT-ProBNP;hsCRP;Cr;FFA;GGT;Blood Pressure;—

Countries

China

Contacts

Public ContactXiao Yi
xiaoyipumch@sina.com+86 010-69155037

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026